1083 related articles for article (PubMed ID: 28131398)
1. Recombinant α-Klotho may be prophylactic and therapeutic for acute to chronic kidney disease progression and uremic cardiomyopathy.
Hu MC; Shi M; Gillings N; Flores B; Takahashi M; Kuro-O M; Moe OW
Kidney Int; 2017 May; 91(5):1104-1114. PubMed ID: 28131398
[TBL] [Abstract][Full Text] [Related]
2. Potential application of klotho in human chronic kidney disease.
Neyra JA; Hu MC
Bone; 2017 Jul; 100():41-49. PubMed ID: 28115282
[TBL] [Abstract][Full Text] [Related]
3. Klotho and phosphate are modulators of pathologic uremic cardiac remodeling.
Hu MC; Shi M; Cho HJ; Adams-Huet B; Paek J; Hill K; Shelton J; Amaral AP; Faul C; Taniguchi M; Wolf M; Brand M; Takahashi M; Kuro-O M; Hill JA; Moe OW
J Am Soc Nephrol; 2015 Jun; 26(6):1290-302. PubMed ID: 25326585
[TBL] [Abstract][Full Text] [Related]
4. αKlotho Mitigates Progression of AKI to CKD through Activation of Autophagy.
Shi M; Flores B; Gillings N; Bian A; Cho HJ; Yan S; Liu Y; Levine B; Moe OW; Hu MC
J Am Soc Nephrol; 2016 Aug; 27(8):2331-45. PubMed ID: 26701976
[TBL] [Abstract][Full Text] [Related]
5. Effect of NAD+ boosting on kidney ischemia-reperfusion injury.
Morevati M; Egstrand S; Nordholm A; Mace ML; Andersen CB; Salmani R; Olgaard K; Lewin E
PLoS One; 2021; 16(6):e0252554. PubMed ID: 34061900
[TBL] [Abstract][Full Text] [Related]
6. Soluble Klotho Protects against Uremic Cardiomyopathy Independently of Fibroblast Growth Factor 23 and Phosphate.
Xie J; Yoon J; An SW; Kuro-o M; Huang CL
J Am Soc Nephrol; 2015 May; 26(5):1150-60. PubMed ID: 25475745
[TBL] [Abstract][Full Text] [Related]
7. Unilateral Renal Ischemia-Reperfusion as a Robust Model for Acute to Chronic Kidney Injury in Mice.
Le Clef N; Verhulst A; D'Haese PC; Vervaet BA
PLoS One; 2016; 11(3):e0152153. PubMed ID: 27007127
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of kidney protective factors by inflammation: role of transcription factors and epigenetic mechanisms.
Ruiz-Andres O; Sanchez-Niño MD; Moreno JA; Ruiz-Ortega M; Ramos AM; Sanz AB; Ortiz A
Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1329-F1340. PubMed ID: 27760772
[TBL] [Abstract][Full Text] [Related]
9. C-terminal fragment of fibroblast growth factor 23 improves heart function in murine models of high intact fibroblast growth factor 23.
Hu MC; Reneau JA; Shi M; Takahashi M; Chen G; Mohammadi M; Moe OW
Am J Physiol Renal Physiol; 2024 Apr; 326(4):F584-F599. PubMed ID: 38299214
[TBL] [Abstract][Full Text] [Related]
10. Klotho as a potential biomarker and therapy for acute kidney injury.
Hu MC; Moe OW
Nat Rev Nephrol; 2012 Jun; 8(7):423-9. PubMed ID: 22664739
[TBL] [Abstract][Full Text] [Related]
11. The axis of local cardiac endogenous Klotho-TGF-β1-Wnt signaling mediates cardiac fibrosis in human.
Liu Q; Zhu LJ; Waaga-Gasser AM; Ding Y; Cao M; Jadhav SJ; Kirollos S; Shekar PS; Padera RF; Chang YC; Xu X; Zeisberg EM; Charytan DM; Hsiao LL
J Mol Cell Cardiol; 2019 Nov; 136():113-124. PubMed ID: 31520610
[TBL] [Abstract][Full Text] [Related]
12. Deficiency of Soluble α-Klotho as an Independent Cause of Uremic Cardiomyopathy.
Xie J; Wu YL; Huang CL
Vitam Horm; 2016; 101():311-30. PubMed ID: 27125747
[TBL] [Abstract][Full Text] [Related]
13. The role of fibroblast growth factor 23 and Klotho in uremic cardiomyopathy.
Grabner A; Faul C
Curr Opin Nephrol Hypertens; 2016 Jul; 25(4):314-24. PubMed ID: 27219043
[TBL] [Abstract][Full Text] [Related]
14. Klotho restoration via acetylation of Peroxisome Proliferation-Activated Receptor γ reduces the progression of chronic kidney disease.
Lin W; Zhang Q; Liu L; Yin S; Liu Z; Cao W
Kidney Int; 2017 Sep; 92(3):669-679. PubMed ID: 28416226
[TBL] [Abstract][Full Text] [Related]
15. Klotho deficiency is an early biomarker of renal ischemia-reperfusion injury and its replacement is protective.
Hu MC; Shi M; Zhang J; Quiñones H; Kuro-o M; Moe OW
Kidney Int; 2010 Dec; 78(12):1240-51. PubMed ID: 20861825
[TBL] [Abstract][Full Text] [Related]
16. The emerging role of Klotho in clinical nephrology.
Hu MC; Kuro-o M; Moe OW
Nephrol Dial Transplant; 2012 Jul; 27(7):2650-7. PubMed ID: 22802580
[TBL] [Abstract][Full Text] [Related]
17. Capillary rarefaction is more closely associated with CKD progression after cisplatin, rhabdomyolysis, and ischemia-reperfusion-induced AKI than renal fibrosis.
Menshikh A; Scarfe L; Delgado R; Finney C; Zhu Y; Yang H; de Caestecker MP
Am J Physiol Renal Physiol; 2019 Nov; 317(5):F1383-F1397. PubMed ID: 31509009
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast Growth Factor 23 and Klotho in AKI.
Christov M; Neyra JA; Gupta S; Leaf DE
Semin Nephrol; 2019 Jan; 39(1):57-75. PubMed ID: 30606408
[TBL] [Abstract][Full Text] [Related]
19. Delayed spironolactone administration prevents the transition from acute kidney injury to chronic kidney disease through improving renal inflammation.
Barrera-Chimal J; Rocha L; Amador-Martínez I; Pérez-Villalva R; González R; Cortés-González C; Uribe N; Ramírez V; Berman N; Gamba G; Bobadilla NA
Nephrol Dial Transplant; 2019 May; 34(5):794-801. PubMed ID: 30107561
[TBL] [Abstract][Full Text] [Related]
20. Urinary angiotensinogen predicts progressive chronic kidney disease after an episode of experimental acute kidney injury.
Cui S; Wu L; Feng X; Su H; Zhou Z; Luo W; Su C; Li Y; Shi M; Yang Z; Cao W
Clin Sci (Lond); 2018 Oct; 132(19):2121-2133. PubMed ID: 30224346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
